3. Kuroki S, Saida T, Nukina M, Yoshioka M, Seino J. Three patients with ophthalmoplegia associated with Campylobacter jejuni. Pediatr Neurol. 2001;25:71—4. 4. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 2002;125:2591—625. 5. Kaida K, Kusunoki S. Antibodies to gangliosides and ganglioside complexes in Guillain—Barré syndrome and Fisher syndrome: mini-revi...

INTRODUCTION Differing patterns of neurophysiological abnormalities have been reported in patients with Fisher syndrome. Fisher syndrome is rare, and few series have incorporated prospective serial studies to define the natural history of nerve conduction studies in Guillain-Barré syndrome. METHODS In an ongoing prospective study of Guillain-Barré syndrome patients, patients who presented wit...

In this letter we report a case of Guillain-Barré syndrome associated with infectious mononucleosis. A 20-year-old woman presented to our hospital with weakness of legs and arms. She had felt weakness in her legs for three days and in arms for one day. She had one week history of pharyingitis, muscle pain, and fever. Serological data confi rmed infectious mononucleosis. Electrophysiological fi ...

OBJECTIVE To determine if patients with the Guillain-Barré syndrome are likely to have had Campylobacter jejuni infection before onset of neurologic symptoms. DESIGN A case-control study. SETTING Several university medical centers. PATIENTS Case patients met clinical criteria for the Guillain-Barré syndrome between 1983 and 1990 and had a serum sample collected and frozen within 3 weeks a...

Guillain-Barré syndrome is a relatively common, acute, and rapidly progressive, inflammatory demyelinating polyneuropathy. The diagnosis is usually established on the basis of symptoms and signs, aided by cerebrospinal fluid findings and electrophysiologic criteria. Previously, radiologic examinations have been used only to rule out other spinal abnormalities. We report a case of systemic lupus...

The risk factors for treatment related clinical fluctuations, relapses occurring after initial therapeutic induced stabilisation or improvement, were evaluated in a group of 172 patients with Guillain-Barré syndrome. Clinical, laboratory, and electrodiagnostic features of all 16 patients with Guillain-Barré syndrome with treatment related fluctuations, of whom 13 were retreated, were compared w...

OBJECTIVE To evaluate pulmonary hypertension associated with acute motor sensory axonal neuropathy subtype of Guillain-Barré syndrome. Guillain-Barré syndrome consists of a group of autoimmune disorders that generally manifest as symmetric, progressive, ascending paralysis. There are five subtypes of Guillain-Barré syndrome, and autonomic involvement has been described in all subtypes, includin...

© 2010 The Authors. doi: 10.2340/16501977-0592 Journal Compilation © 2010 Foundation of Rehabilitation Information. ISSN 1650-1977 Objective: To use the International Classification of Functioning, Disability and Health (ICF) to describe and compare patient-reported disability in Guillain-Barré syndrome survivors and persons with multiple sclerosis, and to identify relevant environmental factor...

Sir, We have read with great interest the McGonigal et al. (2010) article, which addresses the pathogenic role of GD1a antibodies and complement activation for node of Ranvier dysfunction. Nodal injury might explain several electrophysiological features and clinical symptoms in patients with Guillain–Barré syndrome including the sometimes rapid recovery from paralysis. In our opinion, the repor...

Olanzapine is the most commonly prescribed atypical antipsychotic drug. Recently there has been increased concern over possible adverse metabolic effects of this drug. The authors describe the first case of Guillain-Barré-like syndrome associated with an olanzapine hypersensitivity reaction. The presence of progressive numbness, motor weakness, or pain in the limbs of patients receiving olanzap...